Skip to main content

Table 2 Demographics of participants included in the study

From: Consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines

Age group (years)

Number (% of total)

  < 20 years

0

 20–29

3 (13 %)

 30–39

18 (75 %)

  ≥ 40

3 (13 %)

Ethnicity

 European

11 (46 %)

 Maori

5 (21 %)

 Pacific Island

4 (17 %)

 Asian

3 (13 %)

 Middle Eastern/Latin American/ African

1 (4 %)

Employed

 Yes

18 (75 %)

Co-morbidities in pregnancy (by consumers)

 Premature rupture of membranes

11 (46 %)

 Multiple pregnancy

10 (42 %)

 High blood pressure/pre-eclampsia

4 (17 %)

 Antepartum Haemorrhage

4 (17 %)

 Diabetes

3 (13 %)

 Intrauterine growth restriction

2 (8 %)

 Othera

4 (17 %)

Complete course of antenatal corticosteroids

 Yes

18 (75 %)

 No

2 (83 %)

 Unsure

4 (17 %)

  1. aOther: 2 participants’ twin-twin transfusion and 2 participants had a cervical cerclage